Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial).
about
A novel 3D label-free monitoring system of hES-derived cardiomyocyte clusters: a step forward to in vitro cardiotoxicity testingDevelopment of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.Odyssey of a cancer nanoparticle: from injection site to site of action.Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.Cardiac spheroids as promising in vitro models to study the human heart microenvironment.Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis.
P2860
Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial).
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@ast
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@en
type
label
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@ast
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@en
prefLabel
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@ast
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@en
P2093
P2860
P356
P1433
P1476
Kinetic targeting of pegylated ...... ing chemotherapy (CARL-trial).
@en
P2093
Annette Hasenburg
Beate Rautenberg
Gerhard Pütz
Jan W Siebers
Jürgen Eckes
Karl Winkler
Martin J Hug
Martin Jansen
Oliver Schmah
Stefan Zschiedrich
P2860
P2888
P356
10.1186/1471-2407-11-337
P407
P577
2011-08-04T00:00:00Z
P5875
P6179
1023618452